Dual-responsive natural killer cell nano-engagers for cancer immunotherapy via inhibiting IL-6/JAK2/STAT3 pathway

被引：0
|
作者：
Meng, Xiangrui [1 ,2 ]
Zhan, Xue [1 ,2 ]
Xiao, Hang [3 ]
Li, Songtao [1 ,2 ]
Zhang, Xuelian [1 ,2 ]
Ma, Li [3 ]
Liu, Yiyao [1 ,4 ]
Tang, Jianyuan [1 ,2 ]
机构：
[1] Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu,611137, China
[2] Clinical School of Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu,611137, China
[3] College of Traditional Chinese Medicine, Capital Medical University, Beijing,100069, China
[4] School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu,610054, China
来源：
Chemical Engineering Journal | / 499卷
关键词：
Compilation and indexing terms; Copyright 2025 Elsevier Inc;
D O I：
156423
中图分类号：
学科分类号：
摘要：
Body fluids - Cancer cells - Cell death - Cytotoxicity - Macroinvertebrates - Mammals - Nanoclay
引用
收藏
相关论文
共 50 条
  • [31] PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6
    Zhong, Longzhu
    Tan, Wanlin
    Yang, Qianqiong
    Zou, Zhaowei
    Zhou, Rui
    Huang, Yongsheng
    Qiu, Zhenghua
    Zheng, Kehong
    Huang, Zonghai
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (06) : 2989 - 3008
  • [32] Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway
    Fan, Cai-Lian
    Liang, Sui
    Ye, Meng-Nan
    Cai, Wan-Jun
    Chen, Miao
    Hou, Yun-Long
    Guo, Jun
    Dai, Yi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (09) : 2607 - 2619
  • [33] Research on the Antitumor Effect of Plumbagin by Inhibiting IL-6/STAT3 Pathway in Large Cell Lung Cancer
    Tao YU Yu FAN Li MA Jun CHEN Sen WEI Zhigang LI Hongyu LIU Haisu WAN Zhihao WU Qinghua ZHOU Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment Tianjin Lung Cancer Institute Tianjin Medical University Hospital Tianjin China
    中国肺癌杂志, 2009, (06) : 508 - 509
  • [34] γ-Tocotrienol inhibits T helper 17 cell differentiation via the IL-6/JAK/STAT3 signaling pathway
    Zhao, Hanqing
    Guo, Xin
    Lei, Yunxuan
    Xia, Wenjie
    Cai, Feiyang
    Zhu, Dehao
    An, Yang
    Xi, Yebin
    Niu, Xiaoyin
    Wang, Zhaojun
    Yue, Tao
    Chen, Guangjie
    MOLECULAR IMMUNOLOGY, 2022, 151 : 126 - 133
  • [35] Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment
    Cheng, Man
    Liu, Ping
    Xu, Lisa X.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 210
  • [36] IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
    Wu, Xiongyan
    Tao, Pan
    Zhou, Quan
    Li, Jie
    Yu, Zhenjia
    Wang, Xiaofeng
    Li, Jiaanfang
    Li, Chen
    Yan, Min
    Zhu, Zhenggang
    Liu, Bingya
    Su, Liping
    ONCOTARGET, 2017, 8 (13) : 20741 - 20750
  • [37] Cinnamaldehyde Regulates the Migration and Apoptosis of Gastric Cancer Cells by Inhibiting the Jak2/Stat3 Pathway
    Geng, Yuan-yuan
    Yang, Shuo
    Liu, Zhi-hao
    Wang, Si-yu
    Ge, Pan
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (08) : 2875 - 2882
  • [38] IL-6 upregulates the expression of IL-6R through the JAK2/STAT3 signalling pathway to promote progression of hepatocellular carcinoma
    Song, Li
    Xu, Ruyue
    Cai, Wenpeng
    Liang, Jiaojiao
    Cao, Niandie
    Gao, Jiafeng
    Tang, Xiaolong
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2023, 98 (01)
  • [39] Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway
    Li, Linjin
    Li, Chengpeng
    Miao, Feilong
    Chen, Wu
    Kong, Xianghui
    Ye, Ruxian
    Wang, Feng
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (18) : 1360 - 1370
  • [40] Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway
    Sun, Kuan-Xue
    Xia, Hong-Wei
    Xia, Rong-Long
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 615 - 621
12345